The purpose of the trixeo study is to conduct a prospective observational study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the initiation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
COPD;
Clinical indication for triple inhalation therapy with formoterol/glycopyrrolate/budesonide;
You may not be if
Life expectancy less than one year;
Clareo Health | NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
